Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression profiling of kidneys derived from Pkd1 conditional knock-out (KO) mice treated by salsalate, tolvaptan, and in combination

ABSTRACT: Computational identification of gene expression pathways or key regulatory factors in the Pkd1 KO kidneys treated by salsalate, tolvaptan, and in combination

ORGANISM(S): Mus musculus

PROVIDER: GSE198340 | GEO | 2023/01/16

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Gene expression profiling of kidneys derived from Pkd1 conditional knock-out (KO) mice treated by Salsalate

Project description:Computational identification of gene expression pathways and key regulatory factors in the Pkd1 KO kidneys treated by Salsalate

2019-10-03 | GSE126454 | GEO

RNA-sequencing for kidneys derived from adult Pkd1 knock-out (KO) mice treated with salsalate for two weeks

Project description:To investigate the early and direct effects of short salsalate administration on gene expression & pathways in polycystic kidney disease. Pkd1 was knocked-out at PN18, and mice remained untreated until PN81, after which half of the experimental group received a two-week salsalate treatment. Mice were sacrificed at PN95

2023-11-30 | GSE220775 | GEO

Gene expression profiling of kidneys derived from Pkd1 conditional knock-out (KO) mice treated by Salsalate

Project description:Gene expression profiling of kidneys derived from Pkd1 conditional knock-out (KO) mice treated by Salsalate

| PRJNA521970 | ENA

Next Generation Sequencing of Pkd1 mutant kidneys

Project description:This study sough to understand the differential gene expression profile of Pkd1 mutant mice kidneys in the setting of miR 17~92 deletion

2017-06-12 | GSE89764 | GEO

Expression data of the kidneys from Pkd1 miR Tg mice treated with metformin

Project description:We investigated the effects of metformin treatment on polycystic kidney disease in a mouse model of Pkd1-deficiency. Kidneys are harvested in postnatal day 63 after 28 days of intraperitoneal injection of metformin (150 mg/kg/day) or saline for control. Total RNA was extracted for microarray analysis. Gene expression profiles were different between treatment and control groups.

2023-07-15 | GSE154590 | GEO

Epigenetic silencing of PKD1 in autosomal dominant polycystic kidney disease

2012-02-16 | GSE35831 | GEO

PKD1

Project description:PKD1 gene and protein study

| PRJEB28230 | ENA

Epigenetic silencing of PKD1 in autosomal dominant polycystic kidney disease

Project description:ADPKD (Autosomal dominant polycystic kidney disease) is the most common inherited disorders and is characterized by growth of numerous cysts filled with fluid in the kidneys. Ultimately, it leads to kidney failure. The mutations of PKD1 and PKD2 account for approximately 85 and 15 percent of ADPKD, respectively. However, the mechanisms related to genetic mutation of PKD1 and PKD2 are still unclear. To investigate altered gene expression levels, Affymetrix microarray was performed using the kidney tissue from normal and ADPKD patients. Total RNAs were isolated from kidney of human normal (49 years old/ male) and ADPKD patients (62 years old/ male, 67 years old/ male) using NucleoSpin® RNA Kit (MACHEREY-NAGEL) according to the manufacturer’s instructions. We used tha Affymetrix GeneChip Human Gene 1.0 ST Array. Per RNA sample, 300 ng was used as the input into the Affymetrix procedure as recommended by the manufacturer's protocol.

2012-02-16 | E-GEOD-35831 | biostudies-arrayexpress

Effects of Pkd1 inactivation defined by important developmental switch in post-natal kidney maturation

Project description:Autosomal dominant polycystic kidney disease (ADPKD) is an important cause of end stage renal disease for which there is no proven therapy 1. Mutations at PKD1 are the principal cause of disease. The disease begins in utero2 and is slowly progressive but it is not known whether cystogenesis is an ongoing process during adult life. We now show that inactivation of Pkd1 in mice prior to post-natal day 13 results in severely cystic kidneys within three weeks, whereas inactivation at day 14 and later results in cysts only after five months. We found that cellular proliferation was not appreciably higher in cystic specimens than in age-matched controls but that the abrupt change in response to Pkd1 inactivation corresponded with a previously unrecognized brake point during renal growth and significant changes in gene expression. These findings suggest that the effects of Pkd1 inactivation are defined by a developmental switch that signals the end of the terminal renal maturation process. These studies show that Pkd1 regulates tubular morphology in both developing and adult kidney but the pathologic consequences of inactivation are defined by the organ’s developmental status, with important clinical implications for our understanding of disease and our approach to therapy. Keywords: Developmental status comparison

2007-12-01 | GSE9167 | GEO

Pkd1 and Pkd2 mRNA cis-inhibition drives polycystic kidney disease progression [Pkd1]

Project description:We report the findings of deletion of the miR17 binding motif from Pkd1 mRNA

2022-02-11 | GSE196588 | GEO